XML 19 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Net loss $ (32,465) $ (14,062)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Impairment of inventory and long-lived assets 40,435 20,372
Depreciation and amortization 7,519 9,181
Amortization of deferred financing costs 205 173
Gain on sale of assets (714) (2,023)
Stock compensation expense 5,763 6,910
Deferred income tax benefit (8,076) (9,315)
Reduction in (excess) tax benefit related to share-based awards 954 (2,149)
Changes in current assets and liabilities:    
Accounts receivable, net 3,915 22,124
Inventories (9,139) (16,496)
Income taxes receivable (11,535) (1,722)
Other current assets (543) 1,939
Accounts payable 4,165 (6,033)
Accrued liabilities (2,153) 159
Income taxes payable (1,759) 2,232
Interest payable 74 13
Net cash (used in) provided by operating activities (3,354) 11,303
Cash flows from investing activities:    
Capital expenditures (8,956) (8,963)
Proceeds from sale of assets 858 2,188
Payments for acquisition, net of cash acquired 0 (1,250)
Purchase of patents and other intangible assets (205) (292)
Net cash used in investing activities (8,303) (8,317)
Cash flows from financing activities:    
Repayments of indebtedness (3,571) (6,571)
Borrowings on revolving credit facility 171,397 204,150
Repayments on revolving credit facility (153,460) (189,461)
Debt issuance costs (147) (10)
(Reduction in) excess tax benefit related to share-based awards (954) 2,149
Purchase of treasury stock related to share-based awards (609) (5,339)
Proceeds from sale of common stock 446 543
Repurchase of common stock 0 (7,260)
Proceeds from exercise of stock options 134 22
Proceeds from noncontrolling interest 0 7
Net cash provided by (used in) financing activities 13,236 (1,770)
Effect of changes in exchange rates on cash and cash equivalents 53 (7)
Net increase in cash and cash equivalents 1,632 1,209
Cash and cash equivalents at the beginning of period 2,208 1,266
Cash and cash equivalents at the end of period $ 3,840 $ 2,475